LQDA Liquidia Technologies Inc

P/E --
Forward P/E 14.08
Price/Sales 8.22
Beta 0.414
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Liquidia Technologies is trading 5.2% up

Liquidia Technologies is trading at $54.06, up 5.2% from a comparison close of $51.40 during regular trading. This is a price-action follow-up, so a separate...

Liquidia's third quarter revenue beats on $223M Yutrepia sales amid major United Therapeutics settlement

Liquidia's third quarter revenue beats on $223M Yutrepia sales amid major United Therapeutics settlement

Liquidia reported third quarter 2026 total revenue of $225.3 million, exceeding consensus estimates behind robust commercial adoption of YUTREPIA. The company...

🟒 Liquidia Technologies is trading 6.86% up today as broader markets climb

Liquidia Technologies is trading at $47.31, up 6.86%, with sharply higher broader markets providing a likely sentiment tailwind. - Price was recorded at 10:41...

🟒 Liquidia Technologies is trading 4.39% up in pre-market ahead of November 10 Q3 results

Liquidia Technologies is trading 4.39% up at $46.35 in pre-market on November 9, 2026, ahead of its third-quarter results scheduled for November 10 at 8:30...

Liquidia Technologies Inc Q3 2026 Earnings Preview: What Analysts Expect on November 10, 2026

For the third quarter of 2026, analysts expect Liquidia Technologies to report consensus revenue of $214.15 million and earnings of $0.77 per share, while the...

πŸ”΄ Liquidia Technologies is trading 4.26% down today amid broad risk-off selling

Liquidia Technologies is trading 4.26% down now at $45.36 amid broad risk-off selling; this does not establish a company-specific cause. - Reuters said...

🟒 Liquidia Technologies is trading 10% up today as biotech and broader markets rally

Liquidia Technologies is trading at $46.83, up 10.12%, in line with biotech and broader-market strength; no clear company-specific announcement explains the...

🟒 Liquidia Technologies is trading 4.22% up in pre-market with no clear company-specific catalyst identified

Liquidia Technologies is trading at $43.98, up 4.22%, with no clear company-specific announcement explaining the November 4 pre-market move. - The company’s...

πŸ”΄ Liquidia Technologies is trading 4.59% down

Liquidia Technologies is trading at $42.99, down 4.59%, with no confirmed catalyst in available sources. - No new company announcement or Q3 results...

Liquidia Technologies Inc Q3 2026 Earnings Preview: What Analysts Expect on November 02, 2026

Liquidia Technologies is projected to report Q3 2026 revenue of $214.18 million and an EPS of $0.77, with the current stock price of $45.88 trading...

🟒 Liquidia Technologies is trading 4.09% up today with no clear catalyst identified

Liquidia Technologies is trading at $45.53, up 4.09%, at 9:46 a.m. EST on October 27, 2026; no specific catalyst for the move was identified. - Shares had...

🟒 Liquidia Technologies is trading 4.08% up today as rally driver remains unclear

Liquidia Technologies is trading at $44.39, up 4.08%, with the specific driver of the October 26 move unclear. - No fresh company-specific announcement...

🟒 Liquidia Technologies is trading 4.12% up β€” no clear session catalyst

Liquidia Technologies is trading at $41.33, up 4.12%, with no fresh company-specific announcement or catalyst identified for the October 23 move. - The...

🟒 Liquidia Technologies is trading 4.48% up today amid broader biotech-sector strength

Liquidia Technologies is trading at $37.98, up 4.48%, as of 9:45 a.m. EST on October 21, 2026, amid biotech-sector strength. - XBI was reported up 2.10%, with...

🟒 Liquidia Technologies is trading 4.59% up today as biotech ETF XBI rose 2.10%

Liquidia Technologies is trading at $35.70, up 4.59%, with biotech-sector strength the clearest available explanation. - Biotech ETF XBI rose 2.10% during the...

🟒 Liquidia Technologies is trading 5.5% up with no new company-specific announcement identified

Liquidia Technologies is trading 5.5% higher at $36.23 on October 19, 2026; no new company-specific announcement explains the move. - The October 13...

🟒 Liquidia Technologies is trading 4.3% up today as settlement preserves YUTREPIA sales for PAH

Liquidia Technologies is trading 4.3% up at $35.40 on October 15, following a settlement allowing uninterrupted YUTREPIA sales for pulmonary arterial...

🟒 Liquidia Technologies is trading 34% up today after settlement secures continued YUTREPIA commercialization

Liquidia Technologies is trading 34.05% up at $35.94 after announcing a global settlement with United Therapeutics on October 13, 2026, resolving six lawsuits...

Liquidia Reaches $380.7M Global Litigation Settlement with United Therapeutics

Liquidia Reaches $380.7M Global Litigation Settlement with United Therapeutics

Liquidia Corporation has entered into a global settlement agreement with United Therapeutics Corporation (UTC) to resolve all ongoing litigation between the...

Liquidia Pays $381 Million to End Its Legal War β€” But Can a One-Drug Company Sustain a 44% Pop?

Liquidia Pays $381 Million to End Its Legal War β€” But Can a One-Drug Company Sustain a 44% Pop?

Shares of Liquidia surged as much as 44% in pre-market trading on October 14 after the company announced a sweeping settlement with United Therapeutics that...